Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lisinopril
Drug ID BADD_D01300
Description Lisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction.[L8384,L8387,L8390] Lisinopril and [captopril] are the only ACEIs that are not prodrugs.[A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.[A184781,A184808,A184817] ACEIs are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers.[A184844] Lisinopril was granted FDA approval on 29 December 1987.[L8384]
Indications and Usage For the treatment of hypertension and symptomatic congestive heart failure. May be used in conjunction with thrombolytic agents, aspirin and/or β-blockers to improve survival in hemodynamically stable individuals following myocardial infarction. May be used to slow the progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
Marketing Status Prescription; Discontinued
ATC Code C09AA03
DrugBank ID DB00722
KEGG ID D00362
MeSH ID D017706
PubChem ID 5362119
TTD Drug ID D07HGR
NDC Product Code 0615-8253; 69117-0037; 63187-775; 76282-418; 0615-8255; 50090-5122; 64220-142; 55289-884; 0615-8254; 68071-1775; 68788-6920; 61919-746; 68071-3123; 71335-0075; 0143-9715; 61919-717; 70518-1316; 0904-6799; 43353-993; 68071-1843; 72865-211; 72865-209; 68645-532; 68071-5190; 70518-1565; 63629-8082; 68071-1672; 63187-534; 65862-042; 0591-0409; 68788-7966; 64679-927; 51655-399; 43547-417; 53002-1178; 50090-2988; 50090-3774; 50436-0352; 43063-480; 43063-074; 55154-2128; 68001-336; 68084-196; 68071-5098; 68788-7831; 61919-942; 55154-8096; 64220-154; 68071-4858; 68071-4871; 42708-096; 68071-5077; 70882-110; 63187-722; 58118-1980; 42708-033; 76282-417; 43353-643; 71610-312; 0591-0408; 68071-3122; 50090-4678; 68001-333; 60760-357; 51655-411; 63629-1761; 60760-360; 52427-441; 64679-928; 50090-2228; 0143-9714; 0591-0885; 31722-179; 43353-297; 0591-0406; 42708-094; 64679-953; 67046-424; 71610-624; 55154-4682; 0185-0605; 50090-2934; 70518-1906; 68645-593; 61919-561; 43547-355; 65862-041; 70518-1156; 0591-0405; 51655-273; 50090-3763; 43547-418; 52427-439; 16729-380; 51655-232; 63187-442; 69117-0015; 68001-334; 43547-415; 71205-626; 0185-0640; 63629-7445; 68071-5143; 69117-0012; 72865-210; 72789-101; 43547-419; 71610-616; 50090-4485; 0904-6800; 65862-039; 65977-0009; 72865-213; 43547-356; 68788-7666; 0904-6797; 52652-3001; 0615-8256; 43547-354; 42708-142; 61919-736; 71610-612; 43063-814; 63187-098; 58118-1981; 50090-3765; 68180-517; 68180-981; 43353-009; 68071-1894; 0615-8252; 69117-0038; 68001-337; 53002-1123; 61919-721; 68071-5090; 71335-0498; 63629-2688; 0615-8405; 72789-093; 68788-7012; 35356-879; 71205-071; 43353-113; 63187-821; 0185-0610; 43353-298; 0591-0407; 68001-332; 50090-4725; 50090-4885; 72969-092; 54458-873; 61919-307; 50090-4887; 70518-3166; 43063-813; 68071-3178; 31722-178; 54458-874; 70518-0701; 68071-4931; 68645-552; 0185-0630; 68071-3043; 67296-1202; 52427-440; 60687-646; 68788-7746; 70518-2561; 65862-038; 43547-352; 15308-0800; 68071-2224; 70518-2600; 52427-443; 70518-2655; 43353-270; 70934-171; 68001-486; 70882-103; 60760-359; 71610-588; 69117-0014; 76282-420; 68084-199; 64679-941; 63629-8736; 71335-1426; 68788-6820; 68180-982; 63187-237; 68180-979; 67651-0225; 55700-547; 54458-872; 65862-037; 0904-7200; 16729-376; 71335-0015; 70934-120; 68645-550; 55154-4992; 72865-212; 51655-335; 65862-040; 43063-800; 0143-9713; 60687-678; 51655-292; 68180-513; 17404-0011; 65730-1301; 76282-421; 71610-536; 16729-379; 68788-6407; 64679-942; 0904-6798; 50436-0354; 70518-1790; 50090-2431; 68788-7334; 43063-815; 43353-301; 60760-455; 31722-172; 43547-414; 60760-380; 31722-176; 71335-0176; 55700-513; 72865-208; 63187-825; 63187-257; 16729-378; 61919-161; 70518-1665; 54458-877; 42708-031; 71335-0354; 68788-6811; 0185-0620; 71335-0536; 43063-786; 31722-180; 63187-780; 63187-099; 60760-358; 55154-2329; 43547-351; 43547-353; 68180-512; 60687-667; 70518-0134; 31722-177; 61919-909; 71205-180; 57297-511; 68645-553; 63629-8823; 50090-3175; 69117-0036; 43063-810; 68788-7633; 68071-5036; 76282-419; 71335-1295; 70934-200; 16729-375; 53002-1463; 50090-0808; 43063-811; 68071-5089; 55154-2131; 43063-769; 76282-422; 42708-032; 63629-5247; 70518-1152; 0185-0602; 71610-406; 70882-104; 71335-1380; 68645-555; 71610-638; 68071-4660; 70518-0117; 50090-4991; 60687-333; 68084-765; 67296-1249; 70518-0544; 70934-155; 60687-656; 68071-5046; 43353-793; 55154-8077; 63827-1012; 68180-980; 43353-662; 55154-8078; 60687-325; 68071-3064; 70518-0468; 68645-554; 16729-377; 50090-3757; 68071-3220; 70934-919; 53002-1225; 68001-335; 60760-390; 52427-438; 68645-587; 43547-416; 43353-271; 43063-812; 60760-438; 67296-1154; 71610-279; 52427-442; 64679-929; 71205-471; 68645-551; 55700-480
Synonyms Lisinopril | Lysinopril | Lisinopril Sulfate (1:2) | Prinivil | Zestril | Lisinopril Maleate (1:1) | MK-521
Chemical Information
Molecular Formula C21H31N3O5
CAS Registry Number 76547-98-3
SMILES C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Blood pressure decreasedAngiotensin-converting enzymeP12821T8257716395257; 16138565; 9270093; 10535720; 9726242; 10620209; 10880412; 8986921; 10999650
CoughB2 bradykinin receptorP30411T2371410904024; 12522467; 11699055; 15894833
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Upper airway obstruction22.02.05.0290.000042%Not Available
Brain injury19.07.03.007; 17.11.01.003--Not Available
Oropharyngeal discomfort22.02.05.027; 07.05.05.008--Not Available
Oropharyngeal pain07.05.05.004; 22.02.05.0220.000303%
Acute kidney injury20.01.03.0160.002639%
Respiratory tract oedema22.02.07.0130.000083%Not Available
Posterior reversible encephalopathy syndrome17.13.02.007--
Drug-induced liver injury09.01.07.023; 12.03.01.0440.000136%Not Available
Drug reaction with eosinophilia and systemic symptoms23.03.05.005; 10.01.01.021--Not Available
Autoimmune haemolytic anaemia10.04.01.005; 01.06.01.0040.000021%Not Available
Mouth swelling07.05.04.007; 23.04.01.020; 10.01.05.0200.000115%Not Available
Intestinal angioedema10.01.05.019; 07.08.03.012; 23.04.01.0190.000887%Not Available
Multiple organ dysfunction syndrome08.01.03.057--
Speech sound disorder19.19.01.0070.000005%Not Available
Ureterolithiasis20.04.02.0040.000052%Not Available
Anaemia of chronic disease01.03.04.0020.000021%Not Available
Bladder transitional cell carcinoma20.03.04.003; 16.08.01.0020.000031%Not Available
Blood aldosterone increased13.10.09.0090.000021%Not Available
Chronic gastritis10.04.04.011; 07.08.02.005; 11.07.01.0160.000063%Not Available
Coeliac disease07.17.01.008; 14.02.01.007; 10.04.04.0120.000042%Not Available
Concomitant disease aggravated08.01.03.0630.000052%Not Available
Electrocardiogram T wave peaked13.14.05.0420.000063%Not Available
Epiglottic oedema22.04.02.0060.000031%Not Available
IgA nephropathy20.05.01.016; 10.02.01.0630.000011%Not Available
Macroglossia07.14.01.011; 03.04.09.0030.000042%Not Available
Renin increased13.09.02.0040.000021%Not Available
Intestinal villi atrophy07.11.03.0100.000063%Not Available
Cervical radiculopathy17.10.02.0030.000021%Not Available
Angiotensin converting enzyme inhibitor foetopathy12.03.03.003; 03.02.02.003; 18.03.03.0040.000027%Not Available
Pulmonary sepsis22.07.01.014; 11.01.11.0140.000008%Not Available
The 21th Page    First    Pre   21 22    Next   Last    Total 22 Pages